Detección de la mutación de la enzima isocitrato deshidrogenasa en gliomas difusos grados II, III y IV

Naranjo-Botero, Pablo; Medina-Zuluaica, Leiby Alejandra; Muñetón-Peña, Carlos Mario; Arango-Viana, Juan Carlos; Ospina-Ospina, Sigifredo.
Med. lab ; 25(4): 709-719, 2021. ilus, Tabs
Artículo en Español | LILACS | ID: biblio-1370842

Documentos relacionados

  1. Distant recurrence in the cerebellar dentate nucleus through the dentato-rubro-thalamo-cortical pathway in supratentorial glioma cases.
  2. The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma.
  3. New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction.
  4. Conventional and emerging treatments of astrocytomas and oligodendrogliomas.
  5. [Analysis of the difference in MGMT promoter status in gliomas and its significance in prognosis assessment].
  6. Long-term follow up of patients with WHO grade 2 oligodendroglioma.
  7. [Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors. German version].
  8. Glioma Stem Cells: Novel Data Obtained by Single-Cell Sequencing.
  9. RICH2 decreases the mitochondrial number and affects mitochondrial localization in diffuse low-grade glioma-related epilepsy.
  10. Gene expression profiling of 19q-loss astrocytomas suggest a specific pattern associated with the better prognosis.